Top

BMC Neurology

Published in:

Open Access 01-12-2019 | Parkinson's Disease | Correction

Correction to: Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson’s disease: a comparison of 33 human and animal studies

Authors: Erin Oerton, Andreas Bender

Published in: BMC Neurology | Issue 1/2019

Excerpt

Correction to: BMC Neurol (2017) 17:58. …

Oerton E, Bender A. Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson’s disease: a comparison of 33 human and animal studies. BMC Neurol. 2017;17(58). https://doi.org/10.1186/s12883-017-0838-x.

Title: Correction to: Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson’s disease: a comparison of 33 human and animal studies
Authors: Erin Oerton
Andreas Bender
Publication date: 01-12-2019
Publisher: BioMed Central
Keyword: Parkinson's Disease
Published in: BMC Neurology / Issue 1/2019
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-019-1240-7

At a glance: The STEP trials

Springer Medicine

Correction to: Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson’s disease: a comparison of 33 human and animal studies

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Recurrent post-partum rhombencephalitis associated with anti-centromere antibody: a case report

Assessment of carotid artery ultrasonography in the presence of an acoustic shadow artifact

Multiple sclerosis and stroke: a systematic review and meta-analysis

Discrepancy in the perception of symptoms of cognitive decline between older adults and their family members: results of the Toyama dementia survey

Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic

Gothenburg Very Early Supported Discharge study (GOTVED): a randomised controlled trial investigating anxiety and overall disability in the first year after stroke